Serum levels of interleukin‐8, tumor necrosis factor‐α and γ‐interferon in Egyptian psoriatic patients and correlation with disease severity

Keywords

Medicine, Psoriasis, Tumor necrosis factor alpha, Cytokine, Immunology

References

• A review of the role of neutrophils in psoriasis and related disordersPeter J. Aronson — 2008
• Serum cytokines and growth factor levels in Japanese patients with psoriasisHidenori Takahashi, Hidekazu Tsuji, Yosuke Hashimoto — 2009
• Interleukin 1 alpha, tumor necrosis factor alpha, and interferon gamma in psoriasis.Takashi Gomi — 1991
• Interleukin-8 plays its role at local level in psoriasis vulgaris.Michael Sticherling — 1999
• CCR6 is required for IL-23-induced psoriasis-like inflammation in mice.Michael N. Hedrick, Anke S. Lonsdorf, Aiko‐Konno Shirakawa — 2009
• Severe psoriasis--oral therapy with a new retinoid.T Fredriksson, U. Pettersson — 1978
• Pathophysiology of psoriasis: Recent advances on IL-23 and Th17 cytokinesErin Fitch, Erin Harper, Iliyana Skorcheva — 2007
• Interleukin 1a, Tumor Necrosis Factor a, and Interferon ? in PsoriasisToshihiko Gomi — 1991
• Serum Levels of TNF-α, IFN-γ, IL-6, IL-8, IL-12, IL-17, and IL-18 in Patients With Active Psoriasis and Correlation With Disease SeverityÖzer Arıcan, Murat Aral, Sezai Şaşmaz — 2005
• The immunology of psoriasis and biologic immunotherapy.Stephanie Mehlis, Kenneth B. Gordon — 2003
• Type I Interferon: Potential Therapeutic Target for Psoriasis?Yihong Yao, Laura K. Richman, Chris Morehouse — 2008
• T helper 1 to T helper 2 shift in cytokine expression: an autoregulatory process in superantigen-associated psoriasis progression?Sarika Jain, Iqbal Kaur, Shukla Das — 2009
• Simultaneous measurement of multiple Th1 and Th2 serum cytokines in psoriasis and correlation with disease severity.Sharon E. Jacob, Mehdi Nassiri, Francisco A. Kerdel — 2003
• Mechanisms of Disease: Psoriasis.Frank O. Nestlé, Daniel H. Kaplan, Jonathan Barker — 2009

Cited by

• Clinical and cytokine profile evaluation in Northeast Brazilian psoriasis plaque-type patientsJohn Borrie, Vanessa Martin Randin — 2016
• Natural killer cells from psoriasis vulgaris patients have reduced levels of cytotoxicity associated degranulation and cytokine production.Sinéad Dunphy, Cheryl Sweeney, G. Kelly — 2017
• Proinflammatory cytokine responses in patients with psoriasisAnargyros Kouris, Aikaterini Pistiki, Alexandros Katoulis — 2014
• Cytokine network in psoriasis revisited.Anna Michalak-Stoma, Aldona Pietrzak, Jacek C. Szepietowski — 2011
• Therapeutic depletion of myeloid lineage leukocytes in patients with generalized pustular psoriasis indicates a major role for neutrophils in the immunopathogenesis of psoriasis.Shigaku Ikeda, Hidetoshi Takahashi, Yasushi Suga — 2013
• EGFR-driven up-regulation of decoy receptor 3 in keratinocytes contributes to the pathogenesis of psoriasis.Nan-Lin Wu, Duen-Yi Huang, Shie‐Liang Hsieh — 2013
• Serum Levels of TNF-α, IL-12/23p40, and IL-17 in Plaque Psoriasis and Their Correlation with Disease SeverityAikaterini Kyriakou, Aikaterini Patsatsi, Timoleon‐Achilleas Vyzantiadis — 2014
• The role of nutrition in dermatologic diseases: facts and controversies.Nikita Lakdawala, Olubukola Babalola, Flavia Fedeles — 2013
• Relationship between retinal sensitivity and disease activity in patients with psoriasis vulgarisHelin Deniz Demir, Göknur Kalkan, Semiha Kurt — 2015
• Psoriasis & Comorbidities: Unraveling the MazeEmmilia A. Dowlatshahi — 2014
• Clastogenic Plasma Factors in Psoriasis—Comparison of Phototherapy and Anti–TNF‐α TreatmentsI Emerit, Joana Antunes, João Maia Silva — 2011
• Infliximab does not lead to reduction in the interferon-gamma and lymphoproliferative responses of patients with moderate to severe psoriasis.Luís Ortigosa, Larissa K. A. da Silva, A Duarte — 2014
• Serum Levels of TNF-α, IL-12/23 p40, and IL-17 in Psoriatic Patients with and without Nail Psoriasis: A Cross-Sectional StudyAikaterini Kyriakou, Aikaterini Patsatsi, Timoleon‐Achilleas Vyzantiadis — 2014
• Markers of systemic inflammation in psoriasis: a systematic review and meta‐analysisEmmilia A. Dowlatshahi, Ella A.M. van der Voort, Lidia R. Arends — 2013
• Role of liver X receptors &agr; and &bgr; in psoriasisRanda M. Youssef, Ghada M. El‐Hanafy, Laila Ahmed Rashed — 2012
• The triad psoriasis–obesity–adipokine profileSusana Coimbra, Cristina Catarino, Alice Santos‐Silva — 2016
• Serum levels of adipokines and cytokines in psoriasis patients: a systematic review and meta-analysisFan Bai, Wen Zheng, Dong Yan — 2017
• Bidirectional Association Between Psoriasis and Obesity: Benefits and RisksNoha A. El-Boghdady, Manal F. Ismail, Mahmoud F. Abd-Alhameed — 2018
• Are New Tools for Early Detection of Psoriatic Arthritis Ready for Widespread Clinical Use? A ReviewBethany D. Wood Harvey, Alice B. Gottlieb — 2013
• The level of proinflammatory cytokines: interleukins 12, 23, 17 and tumor necrosis factor α in patients with metabolic syndrome accompanying severe psoriasis and psoriatic arthritisMagdalena Pirowska, Aleksander Obtułowicz, Sylwia Lipko-Godlewska — 2018

Related papers

• Quality of Life Evaluation in Psoriasis Patients Starting a Biological Treatment: The Importance of a More Comprehensive Assessment of Disease BurdenMarina Talamonti, Marco Galluzzo, Stella Servoli — 2015
• Disease severity measures in a population of psoriasis patients: the symptoms of psoriasis correlate with self-administered psoriasis area severity index scores.Alan B. Fleischer, Steven R. Feldman, Stephen R. Rapp — 1996
• W jaki sposób miarodajnie oceniać nasilenie łuszczycyAgnieszka Bożek, Adam Reich — 2016
• IL-17A, IL-22, and IL-23 as Markers of Psoriasis ActivityChristina Fotiadou, Elizabeth Lazaridou, Eleni Sotiriou — 2015
• Nail Involvement as a Predictor of Disease Severity in Paediatric Psoriasis: Follow-up Data from the Dutch ChildCAPTURE Registry.Inge M. G. J. Bronckers, Finola M. Bruins, Michel van Geel — 2019
• The burden of psoriasis in patients with early psoriatic arthritisFazira R. Kasiem, Marc R. Kok, Jolanda J. Luime — 2021
• Индекс PASI (Psoriasis Area and Severity Index) в оценке клинических проявлений псориазаА. А. Кубанов, Arfenya Е. Karamova, L. F. Znamenskaya — 2016
• Relationship Between Quality of Life and Disease Severity in Patients with PsoriasisKobra Soltandehghan, Tahereh Najafi Ghezeljeh — 2017
• Interleukin-17 serum levels as a vital indicator of psoriatic Iraqi patients in Thi-Qar ProvinceHind M. Mousa, Ahmed Gamal Mohamed Hassan — 2020